Vantage Biosciences

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Eyebiotech Limited

This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.

Foventa Therapeutics

The company develops non-invasive topical eye drops to treat retinal vascular diseases for patients with non-proliferative diabetic retinopathy.

Breye Therapeutics

This biopharmaceutical company develops orally administered medicines for patients with retinal vascular diseases such as diabetic retinopathy and age-related macular degeneration.

Exonate

This biotechnology company develops non-invasive eye drops to treat patients with retinal vascular diseases such as diabetic retinopathy.

Memento Medicines

This biotech company develops biologic therapies for retinal diseases to treat patients with neovascular age-related macular degeneration and diabetic macular edema.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.